Published in Rheumatology (Oxford) on June 07, 2005
Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun (2007) 1.34
Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan. Mod Rheumatol (2011) 0.88
Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review. Clin Rheumatol (2011) 0.82
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report. BMC Infect Dis (2014) 0.79
Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature. Clin Rheumatol (2007) 0.79
Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies. J Neurol (2011) 0.78
Nasal mask ventilation in acute respiratory failure. Experience in elderly patients. Chest (1992) 2.59
A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J (1995) 2.34
Internal jugular vein thrombosis: outcome and risk factors. QJM (2010) 2.24
Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS (1995) 1.80
Tongue involvement revealing sarcoidosis. QJM (2008) 1.68
Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum (2002) 1.67
p56lck interacts via its src homology 2 domain with the ZAP-70 kinase. J Exp Med (1994) 1.60
International approaches to the prescription of long-term oxygen therapy. Eur Respir J (2001) 1.57
An uncommon association: celiac disease and dermatomyositis in adults. Clin Exp Rheumatol (2001) 1.49
Peripheral arterial disease and isolated systolic hypertension: the ATTEST study. J Hum Hypertens (2008) 1.49
Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther (2006) 1.46
Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol (2001) 1.46
[Usefulness of magnetic resonance imaging in Churg-Strauss syndrome related cardiac involvement. A case series of three patients and literature review]. Rev Med Interne (2010) 1.38
Insertional inactivation and cloning of the wA gene of Aspergillus nidulans. Genetics (1990) 1.30
Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) (1999) 1.26
Evaluation of home versus laboratory polysomnography in the diagnosis of sleep apnea syndrome. Am J Respir Crit Care Med (2000) 1.20
The risk of tumoral seeding in needle biopsies. Acta Cytol (1990) 1.17
Cloning of the nitrate reductase gene (niaD) of Aspergillus nidulans and its use for transformation of Fusarium oxysporum. Gene (1989) 1.14
Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. Br J Dermatol (2006) 1.10
Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity. Biochemistry (2001) 1.09
The nucleotide sequence of Saccharomyces cerevisiae chromosome XIV and its evolutionary implications. Nature (1997) 1.09
[Partial monosomy of the short arm of chromosome 10, associated with Rieger's syndrome and a Di George type partial immunodeficiency]. Ann Pediatr (Paris) (1984) 1.08
Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody. Br J Dermatol (2009) 1.07
Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis. Br J Dermatol (2007) 1.01
Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev (2013) 1.00
Respiratory intermediate care units: a European survey. Eur Respir J (2002) 0.99
Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis. Chest (2000) 0.99
Selection criteria and programmes for pulmonary rehabilitation in COPD patients. Rehabilitation and Chronic Care Scientific Group of the European Respiratory Society. Eur Respir J (1997) 0.99
Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function. Am J Transplant (2011) 0.95
Evidence for expiratory flow limitation of extrathoracic origin in patients with obstructive sleep apnoea. Thorax (2002) 0.95
Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. Rheumatology (Oxford) (2009) 0.95
Fabry disease 'The New Great Imposter': results of the French Observatoire in Internal Medicine Departments (FIMeD). Clin Genet (2011) 0.95
Polymyositis, cranial neuropathy, autoimmune hepatitis, and hepatitis C. Ann Rheum Dis (2000) 0.95
Portal vein thrombosis and fatal pulmonary thromboembolism associated with oral contraceptive treatment. J Clin Gastroenterol (1981) 0.94
Acute adrenal failure secondary to bilateral infarction of the adrenal glands as the first manifestation of primary antiphospholipid antibody syndrome. Ann Rheum Dis (1997) 0.94
Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum (2001) 0.94
Ultrastructural localization of interferon-inducible double-stranded RNA-activated enzymes in human cells. Exp Cell Res (1998) 0.93
Structure-function analysis of human cytochrome P-450 2B6 using a novel substrate, site-directed mutagenesis, and molecular modeling. J Pharmacol Exp Ther (1999) 0.92
[Influence of protein S deficiency on the arterial thrombosis risk]. Presse Med (1991) 0.92
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia. Eur Respir J (2003) 0.92
Churg-Strauss syndrome associated with montelukast therapy. QJM (2008) 0.91
Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis. Aliment Pharmacol Ther (2014) 0.91
Home treatment for chronic respiratory insufficiency: the situation in Europe in 1992. The European Working Group on Home Treatment for Chronic Respiratory Insufficiency. Eur Respir J (1994) 0.91
Neutrophilic myositis as an extracutaneous manifestation of neutrophilic dermatosis. J Am Acad Dermatol (2001) 0.90
Cloning of murine SeGpx cDNA and synthesis of mutated GPx proteins in Escherichia coli. Gene (1991) 0.90
Watermelon stomach in systemic sclerosis: its incidence and management. Aliment Pharmacol Ther (2008) 0.90
Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome. Respir Med (2012) 0.90
Löfgren's syndrome as the first manifestation of acute infection due to Chlamydia pneumoniae: a prospective study. Clin Infect Dis (1999) 0.90
The hormonal flare-up following gonadotrophin-releasing hormone agonist administration is influenced by a progestogen pretreatment. Hum Reprod (1996) 0.89
An uncommon association: Sjögren's syndrome and autoimmune myelofibrosis. Rheumatology (Oxford) (1999) 0.89
Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid. Biochem J (1984) 0.89
Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study. J Clin Oncol (2001) 0.88
Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol (1999) 0.88
Typhlitis as a complication of alemtuzumab therapy. Haematologica (2007) 0.88
Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil Aerolizer) with salbutamol (Ventodisk). Respir Med (2001) 0.88
Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats. Arterioscler Thromb Vasc Biol (2000) 0.88
[Acute reactive arthritis after intravesical instillation of bacillus Calmette-Guérin. Two case reports and literature review]. Rev Med Interne (2010) 0.88
Determinants of severity for superficial cellutitis (erysipelas) of the leg: a retrospective study. Eur J Intern Med (2004) 0.88
[Gardner's syndrome and epidermoid cyst of the thymus]. Gastroenterol Clin Biol (1987) 0.86
Diamond-blackfan anemia and growth status: the French registry. J Pediatr (2005) 0.86
Mesenteric venous thrombosis revealing both factor II G20212A mutation and hyperhomocysteinemia related to pernicious anemia. Gastroenterology (2000) 0.86
[Infectious aortic aneurysms. A case series of 10 patients]. Rev Med Interne (2010) 0.85
Study of the expression of the genetic variants of human alpha1-acid glycoprotein in healthy subjects using isoelectric focusing and immunoblotting. J Chromatogr B Biomed Sci Appl (1998) 0.85
Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia. Clin Microbiol Infect (2004) 0.85
Intravenous immunoglobulin for treatment of gastro-intestinal haemorrhage in dermatomyositis. Ann Rheum Dis (2001) 0.84
Assessment of candidate anticryptosporidial agents in an immunosuppressed rat model. J Infect Dis (1993) 0.84
Gastric involvement in systemic sclerosis: a prospective study. Am J Gastroenterol (2001) 0.84
Effects of short-term GnRH agonist--human menopausal gonadotrophin stimulation in patients pre-treated with progestogen. Hum Reprod (1992) 0.84
A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositis. Rev Rhum Engl Ed (1996) 0.84
A low molecular weight heparin decreases plasma aldosterone in patients with primary hyperaldosteronism. Eur J Clin Pharmacol (1992) 0.84
[Hypoglycemia induced by cibenzoline in the elderly]. Rev Med Interne (1991) 0.84
[Pulmonary lymphangioleiomyomatosis: an often fortuitous diagnosis. A case report]. Rev Med Interne (1999) 0.84
Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome. Hum Reprod (1996) 0.83
Clinical approach to inherited metabolic diseases in the neonatal period: a 20-year survey. J Inherit Metab Dis (1989) 0.83
Differences in the binding of thyroid hormones and indoles by rat alpha 1-fetoprotein and serum albumin. Eur J Biochem (1982) 0.83
In vivo imaging of pulmonary alveolar proteinosis using confocal endomicroscopy. Eur Respir J (2010) 0.83
Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome? Rheumatology (Oxford) (2001) 0.82
Intravenous immunoglobulins as treatment of severe cutaneous polyarteritis nodosa. Intern Med J (2012) 0.82
Risk factors of vitamin K antagonist overcoagulation. QJM (2011) 0.82
Long-term efficiency of home nasal mask ventilation in patients with diffuse bronchiectasis and severe chronic respiratory failure: a case-control study. Chest (1997) 0.82
Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology (1997) 0.81
Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients. J Thromb Haemost (2004) 0.81
Drug-binding properties of rat alpha-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites. Biochem J (1986) 0.81
[Muscle lymphoma: a case report]. Rev Med Interne (2008) 0.81
[Sarcoidosis simulating a pulmonary veno-occlusive disease]. Rev Mal Respir (1991) 0.81
[Langerhans histiocytosis in adults: cutaneous and mucous lesion regression after treatment with thalidomide]. Rev Med Interne (1998) 0.81
[Cardiopulmonary function before and after cyclophosphamide treatment in severe systemic sclerosis: comparison of monthly intravenous bolus and autologous haematopoietic stem cell transplantation]. Rev Med Interne (2005) 0.81